Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Seban

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|May 6, 1989
[Kawasaki syndrome]A Bourrillon, E Seban, C Vitoux-Brot
Biochemical and Biophysical Research Communications|August 31, 1990
Characterization of specific binding sites for [3H]-staurosporine on various protein kinasesJ M Herbert, E Seban, J P Maffrand
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitorJ M Herbert, D Frehel, M P Rosso, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|May 6, 1989
[Kawasaki syndrome]A Bourrillon, E Seban, C Vitoux-Brot
Biochemical and Biophysical Research Communications|August 31, 1990
Characterization of specific binding sites for [3H]-staurosporine on various protein kinasesJ M Herbert, E Seban, J P Maffrand
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitorJ M Herbert, D Frehel, M P Rosso, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Pageof 1